FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Savarese John 		2. Issuer Name and Ticker or Trading Symbol

MAKO Surgical Corp. [ MAKO ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

3000 SAND HILL ROAD, BUILDING #1, SUITE 260 		3. Date of Earliest Transaction (MM/DD/YYYY)

3/4/2011
(Street)

MENLO PARK, CA 94025
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   3/4/2011     S    62590   D $20.003   (1) 2283122   I   By Montreux Equity Partners IV. L.P.   (2)
Common Stock   3/7/2011     S    44453   D $19.8478   (3) 2238669   I   By Montreux Equity Partners IV. L.P.   (2)
Common Stock                  2719   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
( 1)  The sale price of the 62,590 shares reported in this Form 4 was between the range of $20.25 per share and $19.90 per share, with a weighted average sale price of $20.003. Full information regarding the number of shares sold at each separate price will be provided to the Commission staff, the Issuer or any security holder of the issuer upon request.
( 2)  The reported securities are owned directly by Montreux Equity Partners IV, L.P. The voting and disposition of the shares held by Montreux Equity Partners IV, L.P. is determined by Montreux Equity Management IV, LLC, the general partner of Montreux Equity Partners IV, L.P. Mr. Savarese is a managing member of Montreux Equity Management IV, LLC. Mr. Savarese disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
( 3)  The sale price of the 44,453 shares reported in this Form 4 was between the range of $20.17 per share and $19.51 per share, with a weighted average sale price of $19.8478. Full information regarding the number of shares sold at each separate price will be provided to the Commission staff, the Issuer or any security holder of the issuer upon request.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Savarese John
3000 SAND HILL ROAD
BUILDING #1, SUITE 260
MENLO PARK, CA 94025 		X



Signatures
/s/ John Savarese 3/7/2011
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Mako Surgical Corp. (MM) Charts.
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Mako Surgical Corp. (MM) Charts.